Tag: FDA generic drug pathway

An Abbreviated New Drug Application (ANDA) is the regulatory pathway used to obtain approval for generic drug products in the United States. Any company planning to market a generic drug in the US must submit an ANDA to the U.S. Food and Drug Administration (FDA) and demonstrate that the product is therapeutically equivalent to a…